查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950444

頸動脈分流器市場按產品類型、材料、設計、技術、最終用戶和分銷管道分類，全球預測（2026-2032）

Carotid Artery Shunt Market by Product Type, Material, Design, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年頸動脈分流市場價值為 2.0568 億美元，預計到 2026 年將成長至 2.2825 億美元，預計到 2032 年將達到 4.5037 億美元，複合年成長率為 11.84%。

關鍵市場統計數據
基準年 2025 2.0568億美元
預計年份：2026年 2.2825億美元
預測年份 2032 4.5037億美元
複合年成長率 (%) 11.84%

頸動脈分流術的臨床作用和採購要求權威概述：影響器械選擇和手術結果的因素

頸動脈分流器在神經血管和血管外科手術中發揮著至關重要的作用，它能在頸動脈介入治療期間維持腦血流。隨著手術技術的不斷發展，臨床醫生和採購團隊都在尋求兼具血流動力學可靠性、易於植入以及與輔助監測技術相容性的裝置。該領域的特點是注重患者安全、高效的手術室工作流程以及能夠無縫整合到現有手術通訊協定中的裝置。

新興的臨床趨勢、法規環境以及流通結構的變化正在重塑頸動脈分流產品在醫療保健領域的開發和應用。

頸動脈分流術的最新趨勢反映了血管外科和醫療設備商業化領域的更廣泛變化。微創手術和混合手術室的興起拓展了頸動脈介入治療的進行場所，迫使器械製造商針對不同的手術環境最佳化分流器的設計。同時，臨床醫生正在採用能夠提供即時血流和壓力回饋的整合監測技術，這也影響著產品的設計和採購策略。

2025年關稅政策引發的供應鏈重組和籌資策略調整將如何影響頸動脈介入裝置的供應、定價和採購選擇

2025年美國關稅政策為依賴全球採購的醫療設備製造商、經銷商和醫療保健系統帶來了新的挑戰。製造商面臨迫在眉睫的成本壓力，被迫重新評估供應商合約、零件籌資策略和庫存管理實務。為此，許多機構加快了區域供應商的資格認證，並重組了採購協議，以降低跨境成本波動帶來的風險。

詳細的細分揭示了最終用戶畫像、產品類型、分銷模式以及材料和技術選擇如何驅動不同的採用模式。

關鍵細分分析揭示了不同使用者群體、產品組合、分銷管道、材料、設計選擇和底層技術的需求促進因素和採用模式的差異。按最終用戶分類，市場涵蓋門診手術中心、診所和醫院，其中醫院進一步細分為教學醫院和社區醫院。這種分層表明，教學醫院傾向於主導具有先進監測功能的設備，而社區醫院則優先考慮易用性和經濟高效的標準解決方案。依產品類型分類，分流器分為直通式分流器和標準腔分流器，直通式分流器又根據 Pruitt Inahara 和 Sundt 等設計進一步細分，而標準腔分流器則根據 Argyle 和 Javid 等產品類型進行分類。這些區分至關重要，因為直通式設計擴大與整合監測功能相結合，而標準腔分流器在以簡單性和成熟的臨床應用為優先考慮的領域仍然更受歡迎。

臨床實務、採購架構和管理體制的區域差異將影響全球市場採納的速度和打入市場策略。

區域趨勢揭示了影響醫療設備應用和策略重點的顯著的臨床、監管和商業特徵。在美洲，醫療保健系統往往更加一體化，採購框架集中化，並更加重視臨床醫生在產品選擇中的影響力，從而創造出以實證醫學和價值論證為關鍵的環境。同時，歐洲、中東和非洲的監管體係錯綜複雜，採購模式多樣，其報銷政策和區域製造夥伴關係將對分銷策略和產品在地化產生重大影響。亞太地區則兼具高運作的公立醫院和快速現代化的私立醫療網路，從而在對技術先進的醫療設備的需求和注重成本效益的選擇之間取得了平衡。

差異化的設備特性、臨床證據項目、夥伴關係和服務模式將重塑競爭格局，進而影響採購和臨床應用。

頸動脈分流術領域的競爭格局主要由產品差異化、實證醫學證據以及為臨床團隊提供的主導支援所驅動。成熟的醫療設備公司和專業血管產品製造商與專注於特定領域設計改進或整合監測功能的小規模創新企業競爭。在高度緊急的醫療環境中，手術效果和安全性是關鍵的決策標準，因此，那些將器械創新與可靠的臨床數據和強大的上市後支援相結合的公司往往更容易獲得市場認可。

針對製造商和醫療系統的實際策略重點，應關注產品互通性、彈性採購、實證應用和適應性商業模式。

產業領導者應優先進行一系列協作，將產品創新、供應鏈韌性和臨床合作相結合，以加速產品上市並降低營運風險。首先，設計和開發策略應強調與術中監測系統的互通性，並優先考慮以使用者為中心的功能，例如縮短插入時間和減少血管損傷。其次，供應鏈策略應包括多元化的採購管道、評估區域製造地，並調整庫存調整週期以應對地緣政治因素和關稅的衝擊。

採用嚴謹的混合方法調查方法，結合臨床醫生訪談、監管審查和多學科檢驗，以得出可操作的策略見解。

我們的研究方法結合了結構化的初步調查（受訪者包括臨床醫生、採購人員和行業高管）和系統的二次研究（包括同行評審文獻、監管資料庫、臨床指南和已發表的技術文件）。初步訪談旨在捕捉關於設備易用性、術中監測偏好和採購決策促進因素的細緻觀點，而二次資訊則為臨床實踐模式和監管考量提供了背景基礎。

綜合分析了臨床效用、技術完整性和供應鏈韌性與永續應用和設備長期影響之間的關聯。

總而言之，頸動脈分流術市場正處於一個轉折點，其促進因素包括臨床對安全性和手術效率的需求、監測技術的進步以及分銷和採購格局的變化。能夠根據實際工作流程調整設備設計並優先考慮互通性和臨床醫生培訓的製造商，將更有利於在學術機構和社區醫療機構中獲得廣泛應用。同樣，供應鏈的韌性和適應性強的商業模式對於在應對地緣政治和關稅相關干擾的同時維持服務水準至關重要。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 頸動脈分流器市場（依產品類型分類）

  • 直通式分流器
  • 標準管腔分流術

9. 按材料分類的頸動脈分流器市場

  • 聚氯乙烯
  • 矽酮

10. 頸動脈分流術市場設計

  • 閉型
  • 開放型

第11章 頸動脈分流術市場（依技術分類）

  • 綜合監測
    • 流量監測
    • 壓力監測
  • 標準

第12章 頸動脈分流市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院
    • 大學醫院
    • 社區醫院

第13章 頸動脈分流市場（依通路分類）

  • 直銷
  • 經銷商
    • 集團採購組織
    • 獨立經銷商

第14章 頸動脈分流市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 頸動脈分流市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國頸動脈分流市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國頸動脈分流市場

第18章：中國頸動脈分流市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bentley InnoMed GmbH
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CryoLife, Inc.
  • Halyard Health, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular, Inc.
  • Maquet Cardiovascular LLC
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation
  • Synovis Micro Companies Alliance, Inc.
  • Teleflex Incorporated
  • Terumo Aortic
  • Terumo Corporation
  • Vascular Solutions LLC
  • WL Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4F7A6D4FD86A

The Carotid Artery Shunt Market was valued at USD 205.68 million in 2025 and is projected to grow to USD 228.25 million in 2026, with a CAGR of 11.84%, reaching USD 450.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 205.68 million
Estimated Year [2026] USD 228.25 million
Forecast Year [2032] USD 450.37 million
CAGR (%) 11.84%

An authoritative overview of carotid artery shunt clinical roles and procurement imperatives shaping device selection and procedural outcomes

Carotid artery shunts play a critical role in neurovascular and vascular surgery by preserving cerebral perfusion during carotid interventions. As procedural pathways evolve, clinicians and procurement teams demand devices that combine hemodynamic reliability, ease of insertion, and compatibility with adjunct monitoring technologies. The landscape is characterized by an emphasis on patient safety, streamlined operating-room workflows, and devices that integrate seamlessly into existing surgical protocols.

Moving forward, the interplay between clinical adoption and device innovation will determine which products achieve widespread utilization. Clinicians increasingly prioritize characteristics such as rapid deployability, minimal vessel trauma, and compatibility with intraoperative monitoring. Consequently, decision-makers must balance clinical evidence, hospital procurement dynamics, and supply chain considerations when selecting shunt options for carotid procedures.

Emerging clinical, regulatory, and distribution dynamics that are reshaping carotid shunt product development and adoption across care settings

Recent shifts in the carotid shunt landscape reflect broader changes across vascular surgery and medical device commercialization. Minimally invasive approaches and hybrid operating rooms have broadened the settings in which carotid interventions occur, prompting device makers to optimize shunt profiles for diverse procedural environments. Concurrently, clinicians are embracing integrated monitoring technologies that provide real-time flow and pressure feedback, which in turn influences product design and purchasing preferences.

Regulatory emphasis on device safety and post-market surveillance has also altered how manufacturers approach clinical validation and labeling. In parallel, supply chain modernization and strategic partnerships between manufacturers and group purchasing entities have reconfigured distribution pathways. Taken together, these trends indicate a period of accelerated evolution in which clinical utility, regulatory compliance, and distribution agility collectively determine commercial success.

How 2025 tariff measures triggered supply chain realignments and procurement strategies that affect availability, pricing, and sourcing for carotid devices

The imposition of tariffs in the United States during 2025 introduced a new layer of complexity for medical device manufacturers, distributors, and health systems that rely on global sourcing. Manufacturers faced immediate cost pressures that prompted reassessments of supplier contracts, component sourcing strategies, and inventory management practices. In response, many organizations accelerated regional supplier qualification and restructured procurement agreements to mitigate exposure to cross-border cost volatility.

These tariff-related disruptions also influenced pricing negotiations between manufacturers and healthcare purchasers, with longer procurement cycles and heightened scrutiny of total cost of ownership. At the same time, some manufacturers intensified efforts to localize production or diversify their manufacturing footprint to maintain margin integrity while preserving product availability for clinical pathways. Ultimately, the tariff environment reinforced the importance of supply chain resilience, transparent supplier relationships, and proactive scenario planning for contingency sourcing and inventory buffer strategies.

Granular segmentation reveals how end user profiles, product typologies, distribution models, and material and technology choices drive differentiated adoption patterns

Key segmentation insights illuminate how demand drivers and adoption patterns differ across distinct user groups, product configurations, distribution channels, materials, design choices, and enabling technologies. Based on end user, the market is studied across ambulatory surgical centers, clinics, and hospitals, with hospitals further distinguished between academic medical centers and community hospitals; this stratification reveals that academic centers often lead adoption of advanced monitoring-enabled devices, while community hospitals prioritize ease of use and cost-efficient standard solutions. Based on product type, the market is studied across flow through shunts and standard luminal shunts, with flow through shunts further classified by designs such as Pruitt Inahara and Sundt, and standard luminal shunts further typified by offerings like Argyle and Javid; these distinctions matter because flow through designs are increasingly paired with integrated monitoring while standard luminal designs remain preferred where simplicity and established clinical familiarity are prioritized.

Based on distribution channel, the market is studied across direct sales and distributors, with distributors further segmented into group purchasing organizations and independent distributors; this distribution breakdown highlights divergent go-to-market strategies where direct sales enable close clinical engagement and customized training, whereas distributor-led channels deliver scale and purchasing efficiencies. Based on material, the market is studied across polyvinyl chloride and silicone, each offering trade-offs between flexibility, kink resistance, and sterilization compatibility-choices that can affect clinician preference and inventory policies. Based on design, the market is studied across closed ended and open ended constructs, with open ended options offering certain access advantages while closed ended designs may simplify flow control. Based on technology, the market is studied across integrated monitoring and standard solutions, with integrated monitoring further categorized into flow monitoring and pressure monitoring; this technological segmentation underscores an emergent bifurcation between devices that provide actionable intraoperative metrics and those that focus solely on luminal patency, which in turn shapes clinical protocols and purchasing criteria.

Regional variations in clinical practice, procurement frameworks, and regulatory regimes that determine pace of adoption and go-to-market approaches across global markets

Regional dynamics exhibit distinct clinical, regulatory, and commercial characteristics that influence device uptake and strategic priorities. In the Americas, health systems often emphasize consolidation, centralized procurement frameworks, and strong clinician influence in product selection, creating an environment where evidence generation and value demonstration become pivotal to adoption. In contrast, Europe, Middle East & Africa encompasses a broad regulatory mosaic and diverse purchasing models, where reimbursement policies and regional manufacturing partnerships can materially affect distribution strategies and product localization. Meanwhile, Asia-Pacific presents a combination of high-volume public hospitals and rapidly modernizing private networks, resulting in varied demand for technologically advanced devices alongside cost-sensitive options.

Across all regions, regulatory compliance, clinical training infrastructure, and local manufacturing capabilities shape how quickly new shunt technologies move from introduction to routine use. Consequently, manufacturers and purchasers must tailor market entry and scale-up plans to align with regional reimbursement models, clinician training pathways, and supply chain realities, leveraging partnerships that accelerate clinical validation and procurement alignment.

Competitive landscape shaped by differentiated device features, clinical evidence programs, partnerships, and service models that influence procurement and clinical uptake

Competitive dynamics in the carotid shunt landscape are driven by product differentiation, evidence generation, and service-led support for clinical teams. Established medical device firms and specialist vascular product manufacturers compete alongside smaller innovators that focus on niche design enhancements or integrated monitoring capabilities. Firms that pair device innovation with robust clinical data and strong post-market support tend to achieve greater traction in high-acuity settings where procedural outcomes and safety are primary decision criteria.

Partnerships between device manufacturers and hospital systems or group purchasing organizations have become increasingly important to secure procurement pathways and to co-develop clinical training programs. In addition, strategic collaborations with manufacturers of intraoperative monitoring platforms enhance the clinical value proposition of shunt devices. Firms that invest in surgeon education, multi-disciplinary engagements, and responsive aftermarket logistics are better positioned to support long-term adoption and to adapt to evolving clinical protocols.

Practical strategic priorities for manufacturers and health systems focusing on product interoperability, resilient sourcing, evidence-based adoption, and adaptive commercial models

Industry leaders should prioritize a coordinated set of actions that link product innovation, supply chain resilience, and clinical engagement to accelerate adoption and mitigate operational risk. First, design and development strategies should emphasize interoperability with intraoperative monitoring systems and prioritize user-centered features that reduce insertion time and vessel trauma. Second, supply chain strategies must include multi-sourcing options, regional manufacturing assessments, and inventory cadence adjustments to withstand geopolitical and tariff-driven disruptions.

Third, clinical adoption should be supported by pragmatic evidence-generation plans that combine real-world data collection with targeted clinical training to shorten the learning curve. Fourth, commercial models ought to balance direct engagement with hospitals and partnerships with distributor networks to reconcile the need for clinical support with the efficiencies of scaled distribution. Finally, organizations should develop flexible pricing and contracting constructs that accommodate value-based procurement conversations and that align incentives across clinicians, hospitals, and payers to foster durable adoption.

A rigorous mixed-methods research design integrating clinician interviews, regulatory review, and multi-source validation to support actionable strategic insights

The research approach combined structured primary engagements with clinicians, procurement leaders, and industry executives alongside systematic secondary research across peer-reviewed literature, regulatory databases, clinical guidelines, and publicly available technical documentation. Primary interviews were designed to capture nuanced perspectives on device usability, intraoperative monitoring preferences, and procurement decision drivers, while secondary sources provided contextual grounding on clinical practice patterns and regulatory considerations.

Data synthesis emphasized triangulation of insights, cross-validating clinician-reported preferences with distribution channel feedback and manufacturing perspectives. Segmentation frameworks were developed iteratively to reflect differences in end users, product types, distribution channels, materials, design choices, and enabling technologies. Quality assurance processes included peer review, consistency checks, and sensitivity analyses to ensure that findings are robust and practically relevant for commercial planning and clinical strategy development.

Consolidated conclusions tying clinical utility, technological integration, and supply chain resilience to sustainable adoption and long-term device impact

In summary, the carotid shunt landscape is at an inflection point driven by clinical demand for safety and procedural efficiency, technological advances in monitoring, and evolving distribution and procurement dynamics. Manufacturers that align device design with real-world clinical workflows and prioritize interoperability and clinician training will be better positioned to secure adoption in both academic and community settings. Likewise, supply chain resilience and adaptive commercial models are essential to manage geopolitical and tariff-related disruptions while maintaining service levels.

As stakeholders navigate this environment, the combined emphasis on clinical evidence, operational reliability, and collaborative commercialization will determine which products achieve sustainable integration into surgical practice. Decision-makers should therefore adopt a cross-functional approach that ties clinical validation to procurement strategy and supply chain contingency planning to accelerate safe, effective, and cost-aware adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Carotid Artery Shunt Market, by Product Type

  • 8.1. Flow Through Shunts
  • 8.2. Standard Luminal Shunts

9. Carotid Artery Shunt Market, by Material

  • 9.1. Polyvinyl Chloride
  • 9.2. Silicone

10. Carotid Artery Shunt Market, by Design

  • 10.1. Closed Ended
  • 10.2. Open Ended

11. Carotid Artery Shunt Market, by Technology

  • 11.1. Integrated Monitoring
    • 11.1.1. Flow Monitoring
    • 11.1.2. Pressure Monitoring
  • 11.2. Standard

12. Carotid Artery Shunt Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals
    • 12.3.1. Academic Medical Centers
    • 12.3.2. Community Hospitals

13. Carotid Artery Shunt Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
    • 13.2.1. Group Purchasing Organizations
    • 13.2.2. Independent Distributors

14. Carotid Artery Shunt Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Carotid Artery Shunt Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Carotid Artery Shunt Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Carotid Artery Shunt Market

18. China Carotid Artery Shunt Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International Inc.
  • 19.8. Becton, Dickinson and Company
  • 19.9. Bentley InnoMed GmbH
  • 19.10. Boston Scientific Corporation
  • 19.11. Cardinal Health, Inc.
  • 19.12. CryoLife, Inc.
  • 19.13. Halyard Health, Inc.
  • 19.14. Integra LifeSciences Corporation
  • 19.15. Johnson & Johnson
  • 19.16. JOTEC GmbH
  • 19.17. LeMaitre Vascular, Inc.
  • 19.18. Maquet Cardiovascular LLC
  • 19.19. Medtronic plc
  • 19.20. Merit Medical Systems, Inc.
  • 19.21. Stryker Corporation
  • 19.22. Synovis Micro Companies Alliance, Inc.
  • 19.23. Teleflex Incorporated
  • 19.24. Terumo Aortic
  • 19.25. Terumo Corporation
  • 19.26. Vascular Solutions LLC
  • 19.27. W. L. Gore & Associates, Inc.
  • 19.28. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAROTID ARTERY SHUNT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAROTID ARTERY SHUNT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW THROUGH SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW THROUGH SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW THROUGH SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD LUMINAL SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD LUMINAL SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD LUMINAL SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLOSED ENDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLOSED ENDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLOSED ENDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY OPEN ENDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY OPEN ENDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY OPEN ENDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY FLOW MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRESSURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRESSURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY PRESSURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 160. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 200. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL CAROTID ARTERY SHUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CAROTID ARTERY SHUNT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY INTEGRATED MONITORING, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CAROTID ARTERY SHUNT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)